| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
61,398,000 |
| Market
Cap: |
321.11(M) |
| Last
Volume: |
894,980 |
Avg
Vol: |
703,347 |
| 52
Week Range: |
$3.38 - $6.66 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 803 |
| Guru Rank Value : 1 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile Vanda Pharmaceuticals is a biopharmaceutical company. Co.'s commercial portfolio is comprised of two products, HETLIOZ® for the treatment of Non-24 Sleep-Wake Disorder (Non-24) and nighttime sleep disturbances in Smith-Magenis Syndrome and Fanapt® for the treatment of schizophrenia. In addition, Co. has a number of drugs in development, including: Tradipitant (VLY-686), a small molecule neurokinin-1 receptor antagonist, for the treatment of gastroparesis, motion sickness, atopic dermatitis, and COVID-19 pneumonia; and VTR-297, a small molecule histone deacetylase inhibitor for the treatment of hematologic malignancies and with potential use as a treatment for several oncology indications.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
121,098 |
121,098 |
148,134 |
388,157 |
| Total Sell Value |
$513,345 |
$513,345 |
$684,141 |
$2,735,436 |
| Total People Sold |
5 |
5 |
6 |
8 |
| Total Sell Transactions |
10 |
10 |
14 |
33 |
| End Date |
2024-02-25 |
2023-11-24 |
2023-05-26 |
2022-05-26 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Vitullo Nicole |
10% Owner |
– – • |
2006-12-12 |
4 |
D |
$0.00 |
$0 |
I/I |
(581,176) |
1,954,450 |
|
- |
|
| More Robert J |
10% Owner |
– – • |
2006-12-12 |
4 |
S |
$25.62 |
$330,498 |
I/I |
(12,900) |
21,068 |
|
- |
|
| More Robert J |
10% Owner |
– – • |
2006-12-12 |
4 |
A |
$0.00 |
$0 |
I/I |
9,783 |
20,458 |
|
- |
|
| More Robert J |
10% Owner |
– – • |
2006-12-12 |
4 |
D |
$0.00 |
$0 |
I/I |
(581,176) |
1,954,450 |
|
- |
|
| Schoemaker Kathleen K |
10% Owner |
– – • |
2006-12-12 |
4 |
S |
$25.62 |
$330,498 |
I/I |
(12,900) |
21,068 |
|
- |
|
| Schoemaker Kathleen K |
10% Owner |
– – • |
2006-12-12 |
4 |
A |
$0.00 |
$0 |
I/I |
9,783 |
20,458 |
|
- |
|
| Schoemaker Kathleen K |
10% Owner |
– – • |
2006-12-12 |
4 |
D |
$0.00 |
$0 |
I/I |
(581,176) |
1,954,450 |
|
- |
|
| Treu Jesse I |
10% Owner |
– – • |
2006-12-12 |
4 |
S |
$25.62 |
$330,498 |
I/I |
(12,900) |
21,068 |
|
- |
|
| Treu Jesse I |
10% Owner |
– – • |
2006-12-12 |
4 |
A |
$0.00 |
$0 |
I/I |
9,783 |
20,458 |
|
- |
|
| Treu Jesse I |
10% Owner |
– – • |
2006-12-12 |
4 |
D |
$0.00 |
$0 |
I/I |
(581,176) |
1,954,450 |
|
- |
|
| Dovey Brian H |
10% Owner |
– – • |
2006-12-12 |
4 |
S |
$25.62 |
$330,498 |
I/I |
(12,900) |
21,068 |
|
- |
|
| Dovey Brian H |
10% Owner |
– – • |
2006-12-12 |
4 |
A |
$0.00 |
$0 |
I/I |
9,783 |
20,458 |
|
- |
|
| Dovey Brian H |
10% Owner |
– – • |
2006-12-12 |
4 |
D |
$0.00 |
$0 |
I/I |
(581,176) |
1,954,450 |
|
- |
|
| Blair James C |
10% Owner |
– – • |
2006-12-12 |
4 |
S |
$25.62 |
$330,498 |
I/I |
(12,900) |
21,068 |
|
- |
|
| Blair James C |
10% Owner |
– – • |
2006-12-12 |
4 |
A |
$0.00 |
$0 |
I/I |
9,783 |
20,458 |
|
- |
|
| Blair James C |
10% Owner |
– – • |
2006-12-12 |
4 |
D |
$0.00 |
$0 |
I/I |
(581,176) |
1,954,450 |
|
- |
|
| Phadke Deepak Shripad |
Vice President Manufacturing |
• – – |
2006-12-12 |
4 |
S |
$25.33 |
$119,546 |
D/D |
(4,720) |
0 |
|
- |
|
| Phadke Deepak Shripad |
Vice President Manufacturing |
• – – |
2006-12-12 |
4 |
OE |
$0.33 |
$1,558 |
D/D |
4,720 |
4,720 |
|
- |
|
| Tananbaum James B |
Director |
– • – |
2006-12-11 |
4 |
S |
$26.56 |
$19,616,977 |
I/I |
(738,591) |
11,144 |
|
- |
|
| Shallcross Steven A |
Sr. VP, CFO, Treasurer |
• – – |
2006-12-11 |
4 |
S |
$26.45 |
$264,500 |
D/D |
(10,000) |
0 |
|
- |
|
| Shallcross Steven A |
Sr. VP, CFO, Treasurer |
• – – |
2006-12-11 |
4 |
OE |
$0.83 |
$8,300 |
D/D |
10,000 |
10,000 |
|
- |
|
| Polymeropoulos Mihael Hristos |
Chief Executive Officer |
• • – |
2006-12-11 |
4 |
S |
$25.00 |
$3,872,563 |
D/D |
(150,000) |
0 |
|
- |
|
| Polymeropoulos Mihael Hristos |
Chief Executive Officer |
• • – |
2006-12-11 |
4 |
OE |
$0.33 |
$49,500 |
D/D |
150,000 |
150,000 |
|
- |
|
| Clark William D |
Sr VP, Chief Business Officer |
• – – |
2006-12-11 |
4 |
S |
$26.28 |
$394,166 |
D/D |
(15,000) |
0 |
|
- |
|
| Clark William D |
Sr VP, Chief Business Officer |
• – – |
2006-12-11 |
4 |
OE |
$0.33 |
$4,950 |
D/D |
15,000 |
15,000 |
|
- |
|
554 Records found
|
|
Page 19 of 23 |
|
|
0.32 (6.52%) 
